![](https://investorshub.advfn.com/uicon/269135.png?cb=1492609883)
Wednesday, December 11, 2013 9:58:31 AM
Also, it would help to understand Elite’s timeline of events from at least the beginning of 2011. An understanding of the LPC deal is a must. I also encourage you to look at the patents which Elite has secured and also the ones currently under review. You should also review Elite’s competitors and partners in the abuse resistant technology arena. An understanding of Novel Pharmaceuticals is also a must! Get to know all of the players, and their ties\relationships in the pharma space. In specific, do some research on Epic Pharmaceuticals, Mr. Jerry Treppel and Nasrat Hakim, and familiarize yourself with the 13 ANDA products which were recently purchased by Elite. Review and understand the timing behind the launch of their 8 products and an estimation of revenue projections is important to understand as well.
From a financial perspective, I encourage you to look into the year over comparisons of elite’s metrics, namely revenue, cost of revenue, gross profits, and operating costs for at least the last 7 years. It’s also important to understand the variance in terms of dollars and percentages. Understand the preferred share counts and the history behind the preferred shares. An understanding of the auth\issued\and outstanding share count is important too… as well as an understanding of the industry P\E ratio and understand the value of the company relative to Elites competitors.
Also, pay close attention to the posts on this board. There is lots of good information to glean from…
There, that should get you started.....
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM